SCHEMBL3374783

SCHEMBL3374783

CSCCNC(=O)c1cccc(OS(=O)(=O)C(F)(F)F)c1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HPGD P15428 5/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPK1 P28482 2/20 0.39
TP53 P04637 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
PKM P14618 1/20 0.37
POLB P06746 1/20 0.37
HCRTR1 O43613 2/20 0.37
DRD2 P14416 2/20 0.36
DRD3 P35462 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3374780 0.91 POLB (0.39) MEN1KMT2AHPGDNPC1RAB9A
SCHEMBL3376184 0.89 ALDH1A1 (0.40) MEN1KMT2AHPGDNPC1RAB9A
SCHEMBL3377451 0.87 MEN1 (0.44) MEN1KMT2AHPGDNPC1RAB9A
SCHEMBL3377423 0.87 DRD2 (0.44) MEN1KMT2ARXFP1ALDH1A1POLB
SCHEMBL3377883 0.86 HCRTR1 (0.41) MEN1KMT2AHPGDNPC1RAB9A
SCHEMBL3378266 0.85 TSHR (0.50) MEN1KMT2AHPGDSMN1; SMN2L3MBTL1
SCHEMBL6227836 0.83 KCNA3 (0.38) MEN1KMT2AHPGDNPC1RAB9A
SCHEMBL3376138 0.82 POLB (0.45) MEN1KMT2AHPGDSMN1; SMN2TP53
SCHEMBL3377677 0.81 MEN1 (0.37) MEN1KMT2AHPGDRAB9ARXFP1
SCHEMBL3377641 0.81 NPSR1 (0.40) L3MBTL1RXFP1DRD2DRD3HTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517886-B1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-11-10 EP disclosed
US-7132455-B2 Phthalamide derivatives BAYER CROPSCIENCE AG (DE) 2006-11-07 US disclosed
US-20060035967-A1 Novel phthalamide derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-02-16 US disclosed
EP-1517886-A1 NOVEL PHTHALAMIDE DERIVATIVES Bayer CropScience AG (DE) 2005-03-30 EP disclosed
WO-2004000796-A1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060035967-A1 Novel phthalamide derivatives HDAC1, HDAC2, CRY1 MEN1 1772/4885KMT2A 102/4885HPGD 2293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.